A novel treatment for refractory primary biliary cirrhosis?

Hepato-Gastroenterology

Volumn 47, Issue 36, 2000, Pages 1518-1521

  Miyaguchi, S ^a   Ebinuma, H ^a   Imaeda, H ^a   Nitta, Y ^a   Watanabe, T ^a   Saito, H ^a   Ishii, H ^a  

^a Toshima ku   (Japan)

Author keywords

Bezafibrate; PBC

Indexed keywords

ALKALINE PHOSPHATASE; BEZAFIBRATE; GAMMA GLUTAMYLTRANSFERASE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIVER ENZYME; METHOTREXATE; PRANLUKAST; PREDNISOLONE; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; CHOLESTASIS; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HYPERLIPIDEMIA; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

AGED; ALKALINE PHOSPHATASE; ANTILIPEMIC AGENTS; BEZAFIBRATE; BIOLOGICAL MARKERS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED;

EID: 0033636090     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Primary biliary cirrhosis
2. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?
3. Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis a Swedish multicenter, double-blind randomised controlled study
4. A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results
5. A placebe-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid
6. The combination of ursodeoxycholic acid and methotrezate for patients with primary biliary cirrhosis: The results of a pirot study
7. Novel therapeutic approach to primary biliary cirrhosis patients: Antieosinophol strategy
8. Eosinophilia in primary biliary cirrhosis
9. Optimal timing of liver trasplantation for primary biliary cirrhosis
10. The development of serum alkaline phosphatase γ-glutamyl transpeptidase in early primary biliary cirrhosis
11. Bezafibrate. An update of its pharmacology and use in the management of dyslipidemia
12. The effect of bezafibrate treatment on serum alkaline phosphatase isoenzyme activities
13. Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid
14. A novel role for ursodeoxycholic acid in inhabiting apoptosis by modulating mitochondrial membrane perturbation
15. Ursodeoxycholic acid-dependent activation of the glucocorticoid receptor